Reactive oxygen species mediate anlotinib-induced apoptosis via activation of endoplasmic reticulum stress in pancreatic cancer
Authors:
Open Access
- 17 September 2020
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 11 (9) , 1-15
Abstract
Anlotinib (AL3818), a novel multi-targeted receptor tyrosine kinase inhibitor, has recently been proven to be an antitumour drug. This study aimed to explore the antitumour effect of anlotinib and its underlying molecular mechanisms in human pancreatic cancer (PC) cells. The anti-proliferative effect of anlotinib for three PC cell lines was validated using CCK-8, colony formation and EdU detection assays. Cell cycle, cell apoptosis, and reactive oxygen species (ROS) detection assays, a PC xenograft model and immunohistochemistry were performed to elucidate the mechanisms by which anlotinib induced tumour lethality in vitro and in vivo. These results demonstrated that anlotinib inhibited proliferation, induced G2/M phase arrest and triggered apoptosis in PC cell lines. Anlotinib induced PC’s apoptosis through the accumulation of ROS which activated the endoplasmic reticulum (ER) stress via PERK/p-eIF2α/ATF4 pathway. Furthermore, we demonstrated that the expression level of Nrf2, an antioxidant protein, increased with anlotinib treatment. Nrf2 knockdown enhanced the pro-apoptotic effect of anlotinib and the expression of the PERK/p-eIF2α/ATF4 pathway. The in vivo results suggested that suppressing Nrf2 improved the antitumour effect of anlotinib on PC cells. These data indicated that the apoptotic effect of anlotinib on PC cells was induced by ER stress via the accumulation of ROS. In the future, anlotinib combined with an Nrf2 inhibitor may provide a new therapeutic strategy for the treatment of human PC.Keywords
Funding Information
- Fundamental Research Funds for the Central Universities
This publication has 38 references indexed in Scilit:
- Molecular Pathways: Reactive Oxygen Species Homeostasis in Cancer Cells and Implications for Cancer TherapyClinical Cancer Research, 2013
- Role of Nrf2 in Oxidative Stress and ToxicityAnnual Review of Pharmacology and Toxicology, 2013
- Dietary flavonoid genistein induces Nrf2 and phase II detoxification gene expression via ERKs and PKC pathways and protects against oxidative stress in Caco‐2 cellsMolecular Nutrition & Food Research, 2012
- PERK is required at the ER-mitochondrial contact sites to convey apoptosis after ROS-based ER stressCell Death & Differentiation, 2012
- The Unfolded Protein Response: From Stress Pathway to Homeostatic RegulationScience, 2011
- Regulation of cancer cell metabolismNature Reviews Cancer, 2011
- A Selective Inhibitor of eIF2α Dephosphorylation Protects Cells from ER StressScience, 2005
- Phase II Trial of the Use of Gemcitabine and 5-Fluorouracil in the Treatment of Advanced Pancreatic and Biliary Tract CancerAmerican Journal of Clinical Oncology, 2003
- ER Stress Regulation of ATF6 Localization by Dissociation of BiP/GRP78 Binding and Unmasking of Golgi Localization SignalsDevelopmental Cell, 2002
- ATF6 Activated by Proteolysis Binds in the Presence of NF-Y (CBF) Directly to thecis-Acting Element Responsible for the Mammalian Unfolded Protein ResponseMolecular and Cellular Biology, 2000